Stay updated with breaking news from Matthew Davids. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Bio Ascend, Vaniam Group's medical education company, this past weekend reconvened the inaugural class of its Academy of Next Wave of...
Penn State Scranton students made a big donation to a local nonprofit as part of a class project this week.“I mean starting out with a drive, you never know exa
Catherine C. Coombs, MD, and Alexey Danilov, MD, PhD, moderate a discussion on the role and sequencing of BTK inhibitors, venetoclax-based regimens, and CAR T-cell therapy in mantle cell lymphoma and chronic lymphocytic leukemia.
The Community Justice Center (CJC), a collaborative between Tompkins County and the City of Ithaca to implement joint Reimagining Public Safety plans, has announced the hiring of Matthew Davids as
-Medtech_THAI_STUDIO_LAB_249_5668a625a9ad46978c78f22fdb7af040-620x480.jpg)
A three-drug combination that sent chronic lymphocytic leukemia (CLL) into deep remissions in a broad group of patients in a clinical trial is highly effective in patients with high-risk forms of the disease, a new, phase 2 clinical trial led by Dana-Farber Cancer Institute investigators indicates.